Intimation for outcome of Postal Ballot
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Limited announced on December 31, 2025, that shareholders have approved two ordinary resolutions through a Postal Ballot (remote e-voting conducted from December 1-30, 2025). Resolution 1 approves the sub-division/split of equity shares, and Resolution 2 approves the alteration of the Capital Clause of the Memorandum of Association. Both resolutions passed with 99.99% votes in favor, with only 55 and 65 votes against respectively. Out of 16,940 total shareholders, 118 participated in voting. Promoters (holding 4,609,525 shares) voted unanimously in favor, while public non-institutions had a very low turnout of just 0.18% (6,672 shares polled out of 3,654,175). The exact stock split ratio was not disclosed in this filing.
The approved stock split is a positive move that typically makes shares more affordable and improves liquidity, potentially attracting more retail investors. The near-unanimous approval signals strong shareholder confidence, though the low public participation (0.18%) is notable. Investors should watch for the company's next announcement regarding the split ratio and effective date.